子宫内膜异位囊肿手术对卵巢储备的影响:系统综述与荟萃分析
该系统综述与荟萃分析纳入14项前瞻性队列研究共650名女性,评估子宫内膜异位囊肿剥除术对血清抗苗勒管激素(AMH)和窦卵泡计数(AFC)的影响。结果显示术后AMH在早期、中期和晚期分别显著下降1.77、1.17和2.13 ng/mL,而AFC无显著变化。结论认为囊肿剥除术与AMH显著降低相关,AMH或能更准确评估医源性卵巢储备耗竭风险。
要点
- 子宫内膜异位囊肿剥除术后AMH在早期、中期和晚期均显著下降。
- 术后AFC在三个时间点均无显著变化。
- AMH可能比AFC更准确反映医源性卵巢储备耗竭风险。
核心结论
- 子宫内膜异位囊肿剥除术与血清AMH显著降低相关,但与AFC变化无显著关联。
- AMH降低在术后早期、中期和晚期均持续可检测到。
- 对于子宫内膜异位囊肿女性,AMH水平可能更准确评估医源性卵巢储备耗竭风险。
研究设计与样本
- 系统综述与荟萃分析,纳入14项前瞻性队列研究,共650名女性。
- 仅纳入在同一女性中同时测量AMH和AFC、相同时间点及相同设置的前瞻性队列研究。
主要发现
- 术后AMH加权均数差在早期(1-6周)下降1.77 ng/mL(95%CI 0.77-2.77;P<.001),中期(2-6个月)下降1.17 ng/mL(95%CI 0.66-1.67;P<.001),晚期(9-18个月)下降2.13 ng/mL(95%CI 1.61-2.65;P<.001)。
- 对应三个时间点AMH平均降低百分比分别为44.4%、35.1%和54.2%。
- 术后AFC加权均数差在早期为0.70(95%CI -2.71至3.56;P=.63),中期为-0.94(95%CI -2.53至0.65;P=.25),晚期为2.58(95%CI -0.43至5.58;P=.09),均无显著变化。
- AMH和AFC在三个时间点均存在高度异质性(I²分别为92%-94%和94%-98%),比较相似AMH检测方法后异质性减弱,荟萃回归提示年龄未贡献于异质性。
临床怎么用
- 术前咨询应告知子宫内膜异位囊肿剥除术可能显著降低AMH,尤其在术后晚期。
- AMH可作为评估医源性卵巢储备耗竭风险的更准确指标,优于AFC。
- 术后应监测AMH水平以评估卵巢储备变化。
局限性
- 纳入研究存在高度异质性(I²最高达98%)。
- 仅纳入前瞻性队列研究,可能存在选择偏倚。
- AMH检测方法差异可能影响结果一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Accurate preoperative counseling about whether an endometriotic cystectomy has a detrimental effect on the ovarian reserve has been a considerable challenge, because studies assessing the postoperative antral follicle counts and anti-Müllerian hormone levels have reported conflicting results. Our objective was to explore the impact of endometriotic cystectomy on both the anti-Müllerian hormone levels and antral follicle counts, with focus on prospective studies in which both variables were measured for each woman concurrently (overcoming unmeasured confounding), in the same setting (overcoming surgical technique differences), and at the same 3 postoperative time points, namely early (1-6 weeks), intermediate (2-6 months) and late (9-18 months), to overcome time-sensitive changes. DATA SOURCES: Databases of PubMed, ClinicalTrials.gov, the Cochrane Library, Web of Science, and EBSCO were searched between January 2000 and October 2020. STUDY ELIGIBILITY CRITERIA: Only prospective cohort studies that evaluated the impact of endometriotic stripping cystectomy on anti-Müllerian hormone levels and antral follicle counts in the same women, at matching time points, and in the same setting were eligible. STUDY APPRAISAL AND SYNTHESIS METHODS: Two authors performed the screening and data extraction independently. RESULTS: A total of 14 prospectively designed studies were eligible for the meta-analysis and included 650 women. The included studies had a low risk of bias. The postoperative weighted mean differences in serum anti-Müllerian hormone levels dropped significantly when compared with the preoperative levels by an estimated 1.77 ng/mL (95% confidence interval, 0.77-2.77; P<.001), 1.17 ng/mL (95% confidence interval, 0.66-1.67; P<.001), and 2.13 ng/mL (95% confidence interval, 1.61-2.65; P<.001) at the early (1-6 weeks), intermediate (2-6 months), and late (9-18 months) time points, respectively. This corresponded to a mean reduction in serum anti-Müllerian hormone levels at each of the 3-time points of 44.4%, 35.1%, and 54.2%, respectively. Conversely, the postoperative weighted mean difference in the antral follicle count estimates did not change significantly at any of the 3 time points; the early antral follicle count was 0.70 (95% confidence interval, -2.71 to 3.56; P=.63), the intermediate count was -0.94 (95% confidence interval, -2.53 to 0.65; P=.25), and the late count was 2.58 (95% confidence interval, -0.43 to 5.58; P=.09). Overall, high levels of heterogeneity were encountered (I2 ranging between 92% and 94% for the anti-Müllerian hormone levels and between 94% and 98% for the antral follicle counts at the 3 time points), which were attenuated when similar anti-Müllerian hormone assays were compared, and the meta-regression suggested that age did not contribute to heterogeneity. CONCLUSION: Endometriotic cystectomies are associated with a significant reduction in the serum anti-Müllerian hormone levels but not in the antral follicle counts, with the detrimental effects on the anti-Müllerian hormone levels consistently detectable at the early-, intermediate-, and late-postoperative time points. In women with endometrioma, the anti-Müllerian hormone level may provide a more accurate assessment of the risk for iatrogenic depletion of the ovarian reserve.
引用
- Younis JS, Shapso N, Ben-Sira Y, et al. Endometrioma surgery-a systematic review and meta-analysis of the effect on antral follicle count and anti-Müllerian hormone. Am J Obstet Gynecol. 2021. PMID: 34265271. doi:10.1016/j.ajog.2021.06.102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。